These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 30361288)

  • 41. Quantitative Microbial Risk Assessment of Pharmaceutical Products.
    Eissa ME
    PDA J Pharm Sci Technol; 2017; 71(3):245-251. PubMed ID: 27974628
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Extractables Screening of Polypropylene Resins Used in Pharmaceutical Packaging for Safety Hazards.
    Jenke D
    PDA J Pharm Sci Technol; 2017; 71(5):346-367. PubMed ID: 28512176
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk-based Strategy to Determine Testing Requirement for the Removal of Residual Process Reagents as Process-related Impurities in Bioprocesses.
    Qiu J; Li K; Miller K; Raghani A
    PDA J Pharm Sci Technol; 2015; 69(3):334-45. PubMed ID: 26048741
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Deriving harmonised permitted daily exposures (PDEs) for paracetamol (acetaminophen) CAS #: 103-90-2.
    Gromek K; Hawkins W; Bernier T; Sehner C; Zeller E; Schwind M; Pfister T; Kohan M; Osadolor O; Glogovac M; Tuschl G; Dolan DG; Lovsin Barle E
    Regul Toxicol Pharmacol; 2020 Aug; 115():104692. PubMed ID: 32522580
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aseptic process monitoring--a better strategy. Validation Group, Inc.
    Wilson JD
    PDA J Pharm Sci Technol; 1999; 53(3):111-4. PubMed ID: 10754699
    [No Abstract]   [Full Text] [Related]  

  • 46. Cleaning characterization of protein drug products using UV-vis spectroscopy.
    Rathore N; Qi W; Ji W
    Biotechnol Prog; 2008; 24(3):684-90. PubMed ID: 18426244
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A QRM Discussion of Microbial Contamination of Non-sterile Drug Products, Using FDA and EMA Warning Letters Recorded between 2008 and 2016.
    Santos AMC; Doria MS; Meirinhos-Soares L; Almeida AJ; Menezes JC
    PDA J Pharm Sci Technol; 2018; 72(1):62-72. PubMed ID: 29242394
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exposure assessment of pharmaceutical powders based on an environmental monitoring method: a pilot study.
    Demircan Yildirim F; Ekmekci I
    Med Pr; 2020 Dec; 71(6):649-663. PubMed ID: 33107497
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Creating a Holistic Extractables and Leachables (E&L) Program for Biotechnology Products.
    Li K; Rogers G; Nashed-Samuel Y; Lee H; Mire-Sluis A; Cherney B; Forster R; Yeh P; Markovic I
    PDA J Pharm Sci Technol; 2015; 69(5):590-619. PubMed ID: 26429108
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Campaign manufacturing of highly active or sensitizing drugs: a comparison between the GMPs of various Regulatory Agencies.
    Petrelli F; Scuri S; Grappasonni I; Nguyen CTT; Cocchini A; Magrini E; Caraffa A
    Clin Ter; 2020; 170(1):e66-e73. PubMed ID: 31850487
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Investigation of an alternative approach for real-time cleaning verification in the pharmaceutical industry.
    Sarwar A; McSweeney C; Smith M; Timmermans J; Moore E
    Analyst; 2020 Nov; 145(22):7429-7436. PubMed ID: 32955041
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A harmonization effort for acceptable daily exposure derivation - Considerations for application of adjustment factors.
    Sussman RG; Naumann BD; Pfister T; Sehner C; Seaman C; Weideman PA
    Regul Toxicol Pharmacol; 2016 Aug; 79 Suppl 1():S57-66. PubMed ID: 27221789
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fidelity to Science & Correct Scientific Vocabulary-Microbial Control Versus Contamination Control.
    Tidswell EC; Tirumalai R; Hussong D
    PDA J Pharm Sci Technol; 2019; 73(5):510-516. PubMed ID: 31101705
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Manufacturing classification system in the real world: factors influencing manufacturing process choices for filed commercial oral solid dosage formulations, case studies from industry and considerations for continuous processing.
    Leane M; Pitt K; Reynolds GK; Dawson N; Ziegler I; Szepes A; Crean AM; Dall Agnol R; The Manufacturing Classification System McS Working Group
    Pharm Dev Technol; 2018 Dec; 23(10):964-977. PubMed ID: 30320539
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Managing the microbiological quality of pharmaceutical excipients.
    Cundell AM
    PDA J Pharm Sci Technol; 2005; 59(6):381-95. PubMed ID: 16471425
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combating counterfeit drugs.
    Lancet; 2008 May; 371(9624):1551. PubMed ID: 18468523
    [No Abstract]   [Full Text] [Related]  

  • 58. Opportunities and challenges of real-time release testing in biopharmaceutical manufacturing.
    Jiang M; Severson KA; Love JC; Madden H; Swann P; Zang L; Braatz RD
    Biotechnol Bioeng; 2017 Nov; 114(11):2445-2456. PubMed ID: 28710854
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Active pharmaceutical ingredient (API) production involving continuous processes--a process system engineering (PSE)-assisted design framework.
    Cervera-Padrell AE; Skovby T; Kiil S; Gani R; Gernaey KV
    Eur J Pharm Biopharm; 2012 Oct; 82(2):437-56. PubMed ID: 22820647
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proof of concept for a banding scheme to support risk assessments related to multi-product biologics manufacturing.
    Card JW; Fikree H; Haighton LA; Blackwell J; Felice B; Wright TL
    Regul Toxicol Pharmacol; 2015 Nov; 73(2):595-606. PubMed ID: 26361853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.